Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Vilamakitug by XBiotech for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval
Vilamakitug is under clinical development by XBiotech and currently in Phase II for Metastatic Adenocarcinoma of The Pancreas. According to...